| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |